Feedback / Questions
Reolysin (pelareorep) - Oncolytics
https://www.globenewswire.com/news-release/2026/02/04/3232074/0/en/Oncolytics-Biotech-Receives-FDA-Fast-Track-Designation-for-Pelareorep-in-2L-KRAS-Mutant-MSS-Metastatic-Colorectal-Cancer.html
Feb 4, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next